Company / R&D per Share
Idexx Laboratories R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.08
FY2025
5-year range
$1.88 / $3.08
FY2021-FY2025
Trend
+16.3%
vs FY2024
Sector context
#22 of 103
Health Care
What the data says
Idexx Laboratories's r&d per share of $3.08 is higher than 79% of companies in the Health Care sector (FY2025). Improved from $2.30 to $3.08 over the past 2 years.
Based on SEC 10-K filings.
3.08 in FY2025 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Improved from $2.30 to $3.08 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 103This company $3.08 Sector average $2.13
▼
+44.4% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 16.3% year-over-year.
- Ranks #22 out of 103 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.08 | +16.3% |
| FY2024 | $2.65 | +14.9% |
| FY2023 | $2.30 | -23.6% |
| FY2022 | $3.01 | +59.9% |
| FY2021 | $1.88 | +14.0% |
| FY2020 | $1.65 | +6.8% |
| FY2019 | $1.55 | +14.3% |
| FY2018 | $1.35 | +16.1% |
| FY2017 | $1.17 | +17.0% |
| FY2016 | $1.00 | +7.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026